Skip to main content
Figure 4 | Proteome Science

Figure 4

From: Prediction of outcome of non-small cell lung cancer patients treated with chemotherapy and bortezomib by time-course MALDI-TOF-MS serum peptide profiling

Figure 4

Study flowchart. Serum profiling was performed in 27 NSCLC patients. "Feature list 1" represents total number of features before intensity and statistical filters. For each comparison, "Feature list 2" represents the number of differential peptide ions comparing pre-treatment sera (white filled circle), time-course sera (black filled circle) and pre-treatment plus time-course combined (grey filled circle). Accuracy (ac), sensitivity (sn) and specificity (sp) of algorithms are indicated. SVM: support vector machine; LOOCV: leave-one-out-cross validation; pts: patients.

Back to article page

Proteome Science

ISSN: 1477-5956